BrightPath Biotherapeutics Co., Ltd., First Half Net Income Loss Narrows, July-September Net Income Loss Narrows

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Nov 8, 2024 3:30 pm JST Earnings

4594 BrightPath Biotherapeutics Co., Ltd. 【J-GAAP】

Earnings Report

BrightPath Biotherapeutics Co., Ltd. <4594> [TSE-G] announced its financial results after the market closed on November 8th (15:30). The net loss (non-consolidated) for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was a reduced loss of 538 million yen (compared to a loss of 553 million yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the October to March period (second half) is expected to further decrease to loss of 389 million yen (compared to a loss of 615 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the net loss improved to a deficit of loss of 208 million yen (compared to a loss of 258 million yen in the same period last year).

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	0	-805	-809	-810	-14.2	ー	Nov 11, 2022	J-GAAP
Apr - Sep, 2023	0	-550	-551	-553	-8.8	ー	Nov 10, 2023	J-GAAP
Apr - Sep, 2024	0	-542	-537	-538	-7.1	ー	Nov 8, 2024	J-GAAP
YoY	－	+1.5%	+2.5%	+2.7%	+19.3%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Guidance	ー	ー	ー	ー	－	0	May 10, 2024	J-GAAP
Apr - Sep, 2024 Results	0	-542	-537	-538	-7.1	0	Nov 8, 2024	J-GAAP
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	0	-605	-607	-615	-9.6	0	May 10, 2024	J-GAAP
Oct - Mar, 2024 Guidance	0	-383	-388	-389	-4.5	0	Nov 8, 2024	J-GAAP
YoY	－	+36.7%	+36.1%	+36.7%	+53.2%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	5	-1,467	-1,473	-1,485	-24.9	0	May 12, 2023	J-GAAP
Mar, 2024	0	-1,155	-1,158	-1,168	-18.2	0	May 10, 2024	J-GAAP
Mar, 2025 Guidance	0	-925	-925	-927	-10.7	0	May 10, 2024	J-GAAP
YoY	－	+19.9%	+20.1%	+20.6%	+41.3%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	0	-257	-258	-258	-4.1	-Inf	Nov 10, 2023	J-GAAP
Oct - Dec, 2023	0	-397	-396	-400	-6.4	-Inf	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	0	-208	-211	-215	-3.4	-Inf	May 10, 2024	J-GAAP
Apr - Jun, 2024	0	-326	-329	-330	-4.7	-Inf	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	0	-216	-208	-208	-2.8	-Inf	Nov 8, 2024	J-GAAP
YoY	－	+16.0%	+19.4%	+19.4%	+33.1%